Discovery Pharmaceutics and Preformulation Considerations for Enabled Formulations Identifying and overcoming solubility challenges continues to be an important issue for pharmaceutical and biotech drug manufacturers. Estimates of 70% of new drugs still suffer from...
The Next Generation of Drug Delivery: Where Are We Headed? The drug delivery technology market continues to grow rapidly from a technology and application standpoint, particularly in the areas of oral, injectable, topical, nasal, ocular, pulmonary, implantable, and...
In a connection economy, relationships are the new currency. If you want to continue to reach your customers in this hyper-competitive age of social media, your marketing needs to focus on building relationships. Your metrics need to expand beyond ROI to include ROR:...
Chris Brogan is CEO of Owner Media Group, a highly sought after professional speaker, and the New York Times bestselling author of eight books and counting, including The Freaks Shall Inherit the Earth, and Trust Agents. Chris has spoken for or consulted with the...
Decreasing Time-to-Market via Synchrotron Utilization to Discover Stable Formulation Discovering a potent and highly selective API is of course only part of the story of creating a new medicine. Careful consideration of the appropriate dosage form for the patient is...
Technology has made it easier than ever for us to connect and collaborate with colleagues from just about anywhere in the world. With access to products and services at our fingertips, it begs asking the question, is it worth it to spend your dollars and time...
Recent Comments